<DOC>
	<DOCNO>NCT01582815</DOCNO>
	<brief_summary>The purpose study evaluate efficacy overall safety tolerability treatment adjunctive JNJ-40411813 compare placebo patient MDD anxiety symptom treat antidepressant .</brief_summary>
	<brief_title>A Study JNJ-40411813 Supplementary Treatment Antidepressant Adults With Depression Anxiety Symptoms</brief_title>
	<detailed_description>This multicenter , double-blind ( neither physician patient know treatment patient receives ) , placebo-controlled study adult patient Major Depressive Disorder ( MDD ) anxiety symptom relevant severity . The study consist 3 phase : screen phase 2 week , 8-week double-blind treatment phase , 2-week post-treatment ( follow ) phase . Patients continue take daily dose antidepressant ( directed investigator ) time day , screen end study , include post-treatment phase . The total study duration patient approximately 12 week .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Diagnosis Major Depressive Disorder ( MDD ) ; patient diagnosis comorbid Generalized Anxiety Disorder , Social Anxiety Disorder , Panic Disorder may include , investigator considers MDD primary diagnosis A 17item Hamilton Depression Rating Scale ( HDRS17 ) total score = &gt; 18 A HDRS17 anxiety/somatization factor score = &gt; 7 Is receive antidepressant Has psychiatric condition , include , limited , MDD psychotic feature , bipolar disorder , obsessivecompulsive disorder , posttraumatic stress disorder , borderline personality disorder , eat disorder , schizophrenia Has length current Major Depressive Episode ( MDE ) &gt; 6 month Has current recent history clinically significant suicidal ideation within past 6 month , history suicidal behavior within past year Not include inadequate response current antidepressant , 1 fail antidepressant treatment adequate dose duration current MDE</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Anxiety symptom</keyword>
	<keyword>JNJ-40411813</keyword>
</DOC>